# EDGAR Filing Document

**Accession Number:** 0001618500
**File Stem:** 0001213900-25-056410
**Filing Date:** 2025-6
**Character Count:** 5446
**Document Hash:** b5e7a95c7d1a3b05bb6ddd4115f69290
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-056410.hdr.sgml**: 20250623

**ACCESSION NUMBER**: 0001213900-25-056410

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250623

**FILED AS OF DATE**: 20250623

**DATE AS OF CHANGE**: 20250623

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** XYLO TECHNOLOGIES LTD
- **CENTRAL INDEX KEY:** 0001618500
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37381
- **FILM NUMBER:** 251062964

**BUSINESS ADDRESS:**
- **STREET 1:** 10 HANECHOSHET STREET
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971072
- **BUSINESS PHONE:** 972-3-6899124

**MAIL ADDRESS:**
- **STREET 1:** 10 HANECHOSHET STREET
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971072

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medigus Ltd.
- **DATE OF NAME CHANGE:** 20140903

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of June 2025

Commission File Number 001-37381

**XYLO TECHNOLOGIES LTD.**

(Translation of registrant's name into English)

**10 HaNechoshet Street Tel-Aviv, 6971072, Israel**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**EXPLANATORY NOTE**

Xylo Technologies Ltd. (the "Company") hereby announces that on June 22, 2025, the district court of Tel Aviv (Economic Division) (the "Court") approved the arrangement (the "Arrangement") between the Company and its shareholders, pursuant to Section 350 of the Israeli Companies Law, 5759-1999 and the regulations promulgated thereunder. The Arrangement was previously approved by the Company's shareholders at special general meetings held on May 27, 2025. The Court has mandated that the Arrangement be consummated within 180 days of June 22, 2025.

Following the Court's approval, the Company expects to consummate the Arrangement in accordance with the terms previously disclosed. Upon consummation of the Arrangement, the Company will become a wholly-owned subsidiary of L.I.A. Pure Capital Ltd. (the "Applicant"), as the Applicant will purchase all of the issued and outstanding share capital of the Company that it does not already own. As a result, the Company's American Depositary Shares will be delisted from the Nasdaq Stock Exchange, and its obligations as a public company will be terminated.

The Company will update shareholders on the anticipated timeline for closing and any additional procedures as further information becomes available.

**<u>Forward Looking Statement</u>**

This Report of Foreign Private Issuer contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on the Company's current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of the Company could differ materially from those described in or implied by the statements in this Report of Foreign Private Issuer on Form 6-K.

The forward-looking statements contained or implied in this Report of Foreign Private Issuer on Form 6-K are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

This Form 6-K is incorporated by reference into the Company's Registration Statements on [Form F-3](https://www.sec.gov/Archives/edgar/data/1618500/000121390023040557/ea178653-f3_medigus.htm) (File No. 333-271984) and Form S-8 (File No. [333-274190](https://www.sec.gov/Archives/edgar/data/1618500/000121390023070614/ea183957-s8_medigusltd.htm), File No. [333-258624](https://www.sec.gov/Archives/edgar/data/1618500/000121390021041043/ea145291-s8_medigusltd.htm), File No. [333-206803](https://www.sec.gov/Archives/edgar/data/1618500/000117891315002798/zk1517300.htm), No. [333-221019](https://www.sec.gov/Archives/edgar/data/1618500/000121390017010731/fs82017_medigusltd.htm) and No. [333-229429](https://www.sec.gov/Archives/edgar/data/1618500/000121390019001439/fs82019_medigusltd.htm)).

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **XYLO TECHNOLOGIES LTD.** | **XYLO TECHNOLOGIES LTD.** |
| Date: June 23, 2025 | By: | /s/ Tali Dinar |
|  |  | Tali Dinar |
|  |  | Chief Financial Officer |

---